Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 379
Filtrar
1.
Nanotoxicology ; 15(1): 114-130, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33206573

RESUMEN

Understanding the roles of the properties of nanomaterials in biological interactions is a key issue in their safe applications, but the surface atomic arrangement, as an important property of engineered nanomaterials (ENMs), remains largely unknown. Herein, the interfacial interactions (affinity sites and intensity) between monolayer MoS2 and zebrafish embryos mediated by 1 T phase surface atomic arrangement (octahedral coordination) and the 2H phase surface atomic arrangement (triangular prism coordination) MoS2 nanosheets were studied. 1 T-MoS2 first bound to phosphate and then proteins on the chorion, while the adhesion of 2H-MoS2 occurred in the opposite order. The binding affinity of 2H-MoS2 with embryos was higher than that of 1 T-MoS2, and the former material changed the protein structure from ß-sheets to turns and bends and random coils. Compared to 1 T-MoS2, 2H-MoS2 more readily entered embryos, which was facilitated by caveolae-mediated endocytosis, and caused higher developmental toxicity. Furthermore, metabolic pathways related to amino acid and protein biosynthesis and energy metabolism were affected by the nanomaterial surface atomic arrangements. The above results provide insights into the designs, applications and risk assessments of nanomaterials by the surface atomic arrangement regulation.


Asunto(s)
Disulfuros/toxicidad , Embrión no Mamífero/efectos de los fármacos , Molibdeno/toxicidad , Nanoestructuras/química , Nanoestructuras/toxicidad , Animales , Corion/efectos de los fármacos , Disulfuros/química , Endocitosis , Redes y Vías Metabólicas , Molibdeno/química , Pez Cebra
2.
Anim Reprod Sci ; 223: 106623, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33132122

RESUMEN

Chlorooganic xenobiotics (XBs) such as DDT, DDE, aldrin and dieldrin interfere with release of hormones from chorionic villi that are necessary for sustaining the normal course pregnancy: prostaglandins (PGs), oxytocin (OT), progesterone (P4) and estradiol (E2). Approximately 20 %-40 % of these hormones originate from the smooth chorion. The aim of current studies was to investigate effects of these XBs on synthesis and release of PGE2, PGF2α, OT, P4 and E2 from explants of smooth chorion of cattle, obtained during the120-150 and 151-180 day gestational period. Explants were incubated with DDT, DDE, aldrin or dieldrin at concentrations of 1 and 10 ng/mL for 24 h, and concentrations of PGE2, PGF2α, OT, P4 and E2 in post incubation medium and the relative abundances of COX-2, PTGES, AKR1B1, NP-I/OT, PAM, HSD3B, and CYP19A1 mRNA transcripts in tissue explants were determined. The XBs did not have effects on cell viability in explants (P > 0.05), however, there were effects on prostaglandins, OT and P4 secretion and relative abundance of mRNA transcript for genes encoding the main enzymes involved in synthesis of these hormones (P < 0.05). The XBs that were evaluated did not have effects on E2 synthesis and secretion (P > 0.05). In summary, XBs evaluated in the present study had effects on the pattern of prostaglandin secretion, and can increase OT and P4 release from smooth chorion explants. Because XBs inhibit hormonal action throughout the chorion, there is an increase in risk of abortions or premature births in animals.


Asunto(s)
Corion/efectos de los fármacos , Hormonas Esteroides Gonadales/metabolismo , Insecticidas/toxicidad , Oxitocina/metabolismo , Prostaglandinas/metabolismo , Aldrín/toxicidad , Animales , Bovinos , Corion/citología , DDT/toxicidad , Diclorodifenil Dicloroetileno/toxicidad , Dieldrín/toxicidad , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Hormonas Esteroides Gonadales/genética , Oxitocina/genética , Embarazo , Prostaglandinas/genética , Técnicas de Cultivo de Tejidos
3.
Aquat Toxicol ; 229: 105656, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33075613

RESUMEN

Zebrafish have gained popularity as a model organism due to their rapid, external, and transparent development, high fecundity, and gene homology with higher vertebrate models and humans. Specifically, drug discovery has had high success in the implementation of zebrafish in studies for target discovery, efficacy, and toxicity. However, a major limitation of the zebrafish model is a dependence on waterborne exposure in order to maintain high throughput capabilities. Dose delivery can be impeded by a matrix of N-linked glycoproteins and other polypeptides called the chorion. This acelluar barrier is protective of the developing embryo, and thus new approaches for assessment have involved their removal. In these studies, we explored the chorionic interference of a well-characterized alkylating chemotherapeutic, cisplatin, known to accumulate in the chorion of zebrafish and cause delayed hatching. Our results indicated that increased exposure of cisplatin due to dechorionation did not alter morphological endpoints, although retained confinement reduced total body length and yolk utilization. Additionally, inhibition of osteogenesis visualized with Alizarian Red staining, was observable in dechorionated and non-dechorionated treatment groups. The chorions of cisplatin-treated embryos showed resistance to degradation unless treated with a pronase solution. This may be may be due to cisplatin covalently crosslinking which reinforces the structure. As such, the chorion may play an advantageous role in studies to determine alkylating activity of novel compounds. Furthermore, the expression of zebrafish hatching enzyme was not affected by cisplatin exposure. These studies demonstrate that not only was recapitulation of mechanistic activity supported in zebrafish, but highly relevant off-target toxicities observed in higher vertebrates were identified in zebrafish, regardless of chorionation. Experimental design in drug discovery should consider preliminary studies without dechorionation in order to determine dose impediment or off-target adducting.


Asunto(s)
Corion/efectos de los fármacos , Cisplatino/farmacología , Osteogénesis/efectos de los fármacos , Pez Cebra/fisiología , Alquilantes/farmacología , Animales , Reactivos de Enlaces Cruzados/química , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/metabolismo , Contaminantes Químicos del Agua/toxicidad , Pez Cebra/anatomía & histología
4.
Int J Mol Sci ; 21(8)2020 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-32325940

RESUMEN

As the worldwide application of nanomaterials in commercial products increases every year, various nanoparticles from industry might present possible risks to aquatic systems and human health. Presently, there are many unknowns about the toxic effects of nanomaterials, especially because the unique physicochemical properties of nanomaterials affect functional and toxic reactions. In our research, we sought to identify the targets and mechanisms for the deleterious effects of two different sizes (~10 and ~50 nm) of amine-modified silver nanoparticles (AgNPs) in a zebrafish embryo model. Fluorescently labeled AgNPs were taken up into embryos via the chorion. The larger-sized AgNPs (LAS) were distributed throughout developing zebrafish tissues to a greater extent than small-sized AgNPs (SAS), which led to an enlarged chorion pore size. Time-course survivorship revealed dose- and particle size-responsive effects, and consequently triggered abnormal phenotypes. LAS exposure led to lysosomal activity changes and higher number of apoptotic cells distributed among the developmental organs of the zebrafish embryo. Overall, AgNPs of ~50 nm in diameter exhibited different behavior from the ~10-nm-diameter AgNPs. The specific toxic effects caused by these differences in nanoscale particle size may result from the different mechanisms, which remain to be further investigated in a follow-up study.


Asunto(s)
Aminas , Corion/efectos de los fármacos , Embrión no Mamífero/efectos de los fármacos , Nanopartículas del Metal , Plata , Aminas/química , Animales , Apoptosis , Fenómenos Químicos , Desarrollo Embrionario , Lisosomas/metabolismo , Nanopartículas del Metal/administración & dosificación , Nanopartículas del Metal/efectos adversos , Nanopartículas del Metal/química , Tamaño de la Partícula , Plata/química , Pruebas de Toxicidad Aguda , Pez Cebra
5.
ACS Appl Mater Interfaces ; 12(12): 13587-13597, 2020 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-32107914

RESUMEN

Biomaterials for tissue engineering include natural and synthetic polymers, but their clinical application is still limited due to various disadvantages associated with the use of these polymers. This uncertainty of the polymeric approach in tissue engineering launches an opportunity to address a key question: can we eliminate the disadvantages of both natural and synthetic polymers by combining them to form a synergistic relationship? To answer this question, we fabricated scaffolds from elastin, collagen, fibrin, and electrospun polycaprolactone (PCL) with different ratios. The material characterization of these scaffolds investigated degradation, water contact angle, angiogenesis by an ex ovo chorion allantoic membrane (CAM) assay, and mechanical and structural properties. Biological activity and specific differentiation pathways (MSC, adipogenic, osteogenic, myogenic, and chondrogenic) were studied by using human adipose-derived stem cells. Results indicated that all composite polymers degraded at a different rate, thus affecting their mechanical integrity. Cell-based assays demonstrated continual proliferative and viable properties of the cells on all seeded scaffolds with the particular initiation of a differentiation pathway among which the PCL/collagen/fibrin composite was the most angiogenic material with maximum vasculature. We were able to tailor the physical and biological properties of PCL-based composites to form a synergistic relationship for various tissue regeneration applications.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Células Madre Mesenquimatosas/efectos de los fármacos , Neovascularización Fisiológica/efectos de los fármacos , Polímeros/farmacología , Andamios del Tejido/química , Alantoides/efectos de los fármacos , Alantoides/crecimiento & desarrollo , Animales , Materiales Biocompatibles/síntesis química , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Embrión de Pollo , Corion/efectos de los fármacos , Corion/crecimiento & desarrollo , Colágeno/química , Elastina/química , Fibrina/química , Humanos , Células Madre Mesenquimatosas/citología , Poliésteres/química , Poliésteres/farmacología , Polímeros/síntesis química , Polímeros/química , Ingeniería de Tejidos/métodos
6.
Sci Rep ; 10(1): 242, 2020 01 14.
Artículo en Inglés | MEDLINE | ID: mdl-31937877

RESUMEN

Phloroglucinol (1,3,5 tri-hydroxy-benzene) (PGL), a natural phenolic substance, is a peroxidase inhibitor and has anti-oxidant, anti-diabetic, anti-inflammatory, anti-thrombotic, radio-protective, spasmolytic and anti-cancer activities. PGL, as a medicine, is administered to patients to control the symptoms of irritable bowel syndrome and acute renal colic, in clinical trials. PGL, as a phenolic substance, can cause cytotoxic effects. Administration of PGL up to 300 mg/kg (bw) is well tolerated by animals, while in cell lines its toxicity is developed at concentrations above the dose of 10 µg/ml. Furthermore, it seems that tumor or immortalized cells are more susceptible to the toxic power of PGL, than normal cells. However, studies of its cytotoxic potency, at the cellular level, in complex, differentiated and meta-mitotic biological systems, are still missing. In the present work, we have investigated the toxic activity of PGL in somatic epithelial cells, constituting the follicular compartment of a developing egg-chamber (or, follicle), which directs the choriogenesis (i.e. chorion assembly) process, during late oogenesis of Drosophila melanogaster. Our results reveal that treatment of in vitro growing Drosophila follicles with PGL, at a concentration of 0.2 mM (or, 25.2 µg/ml), does not lead to follicle-cell toxicity, since the protein-synthesis program and developmental pattern of choriogenesis are normally completed. Likewise, the 1 mM dose of PGL was also characterized by lack of toxicity, since the chorionic proteins were physiologically synthesized and the chorion structure appeared unaffected, except for a short developmental delay, being observed. In contrast, concentrations of 10, 20 or 40 mM of PGL unveiled a dose-dependent, increasing, toxic effect, being initiated by interruption of protein synthesis and disassembly of cell-secretory machinery, and, next, followed by fragmentation of the granular endoplasmic reticulum (ER) into vesicles, and formation of autophagic vacuoles. Follicle cells enter into an apoptotic process, with autophagosomes and large vacuoles being formed in the cytoplasm, and nucleus showing protrusions, granular nucleolus and condensed chromatin. PGL, also, proved able to induce disruption of nuclear envelope, activation of nucleus autophagy (nucleophagy) and formation of a syncytium-like pattern being produced by fusion of plasma membranes of two or more individual follicle cells. Altogether, follicle cell-dependent choriogenesis in Drosophila has been herein presented as an excellent, powerful and reliable multi-cellular, differentiated, model biological (animal) system for drug-cytotoxicity assessment, with the versatile compound PGL serving as a characteristic paradigm. In conclusion, PGL is a substance that may act beneficially for a variety of pathological conditions and can be safely used for differentiated somatic -epithelial- cells at clinically low concentrations. At relatively high doses, it could potentially induce apoptotic and autophagic cell death, thus being likely exploited as a therapeutic agent against a number of pathologies, including human malignancies.


Asunto(s)
Corion/efectos de los fármacos , Corion/crecimiento & desarrollo , Drosophila melanogaster/embriología , Floroglucinol/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Drosophila melanogaster/efectos de los fármacos , Femenino , Folículo Ovárico/efectos de los fármacos , Folículo Ovárico/crecimiento & desarrollo , Pruebas de Toxicidad
7.
Placenta ; 89: 1-7, 2020 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-31665659

RESUMEN

INTRODUCTION: We have previously demonstrated two associations of PPROM, (1) inflammation/infection (modeled by tumor necrosis factor (TNF)) and (2) decidual bleeding (modeled by thrombin), both decrease fetal membrane (FM) rupture strength in-vitro. Furthermore, Granulocyte-Macrophage-Colony-Stimulating-Factor (GM-CSF) induced by both TNF and thrombin is a critical intermediate, necessary and sufficient for weakening by either agent. The amnion is the strength component of FM and must weaken for FM to rupture. It is unclear whether GM-CSF weakens amnion (AM) directly, or initially targets choriodecidua (CD) which secondarily releases agents to act on amnion. METHODS: Full thickness FM fragments were treated with/without GM-CSF. Some were preincubated with alpha-lipoic acid (LA), a known inhibitor of FM weakening. The FM fragments were then strength-tested. Separately, FM fragments were initially separated to AM and CD. AM fragments were cultured with Medium ± GM-CSF and then strength-tested. In other experiments, CD fragments were cultured with Medium, GM-CSF, LA, or LA + GM-CSF. Conditioned medium from each group was then incubated with AM. AM was then strength-tested. Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Matrix Metalloproteinases (TIMPs) were analyzed by Mutiplex Elisa. RESULTS: GM-CSF weakened intact FM which was blocked by LA. GM-CSF did not weaken isolated AM. However, GM-CSF conditioned CD media weakened AM and this weakening was inhibited by LA. GM-CSF treatment of CD increased MMPs 2, 9, and 10, and decreased TIMPs 1-3. LA reversed these effects. CONCLUSIONS: GM-CSF does not weaken amnion directly; GM-CSF acts on CD to increase proteases and decrease anti-proteases which secondarily weaken the amnion.


Asunto(s)
Amnios/efectos de los fármacos , Corion/efectos de los fármacos , Rotura Prematura de Membranas Fetales/metabolismo , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Metaloproteinasas de la Matriz/metabolismo , Inhibidores Tisulares de Metaloproteinasas/metabolismo , Amnios/metabolismo , Corion/metabolismo , Medios de Cultivo Condicionados , Femenino , Humanos , Embarazo , Ácido Tióctico/farmacología
8.
Reprod Sci ; 26(3): 394-403, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-29783884

RESUMEN

INTRODUCTION: Oxidative stress-mediated fetal membrane cell aging is activated prematurely in preterm premature rupture of membranes (PPROMs). The mechanism of this phenomenon is largely understudied. Progesterone receptor membrane component 1 (PGRMC1) has been recognized as a potential protective component for maintaining fetal membrane integrity and healthy pregnancies. We aimed to investigate the effects of oxidative stress (represented by hydrogen peroxide [H2O2]) on fetal membrane and chorion cell senescence, p38 mitogen-activated protein kinase (MAPK) phosphorylation, and sirtuin 3 (SIRT3) and to examine the roles of PGRMC1 in these effects. METHODS: Following serum starvation for 24 hours, full-thickness fetal membrane explants and primary chorion cells were treated with H2O2 at 100, 300, and 500 µM for 24 hours. Cells were fixed for cell senescence-associated ß-galactosidase assay. Cell lysates were harvested for quantitive reverse transcription polymerase chain reaction to quantify SIRT3 messenger RNA. Cell lysates were harvested for Western blot to semi-quantify SIRT3 protein and p38 MAPK phosphorylation levels, respectively. To examine the role of PGRMC1, primary chorion cells underwent the same treatment mentioned above following PGRMC1 knockdown using validated PGRMC1-specific small-interfering RNA. RESULTS: Hydrogen peroxide significantly induced cell senescence and p38 MAPK phosphorylation, and it significantly decreased SIRT3 expression in full-thickness fetal membrane explants and chorion cells. These effects were enhanced by PGRMC1 knockdown. DISCUSSION: This study further demonstrated that oxidative stress-induced cell aging is one of the mechanisms of PPROM and PGRMC1 acts as a protective element for maintaining fetal membrane integrity by inhibiting oxidative stress-induced chorion cell aging.


Asunto(s)
Senescencia Celular , Corion/metabolismo , Rotura Prematura de Membranas Fetales/metabolismo , Proteínas de la Membrana/metabolismo , Estrés Oxidativo , Receptores de Progesterona/metabolismo , Corion/efectos de los fármacos , Femenino , Humanos , Peróxido de Hidrógeno/administración & dosificación , Embarazo , Sirtuina 3/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
9.
Arch Anim Nutr ; 72(4): 261-274, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29812957

RESUMEN

Recent studies have shown that L-carnitine supplementation of sows during pregnancy and lactation enhances their reproductive performance, but the underlying mechanisms are still needed to be further confirmed. This study was conducted to investigate the function of L-carnitine on placental development, milk nutrient content and release of hormones in sows. In this experiment, 40 multiparous crossbred sows (Yorkshire × Landrace) were allotted to two groups fed diets with or without a supplemental 50 mg/kg L-carnitine. The experimental diets were fed from d 1 post-coitus until d 21 post-partum. L-carnitine-treated sow had fewer weak piglets (p < 0.05) and a greater percentage of oestrus by 5 after 5-d post-partum (p < 0.05) than control sows. The percentage fat from colostrum was greater in L-carnitine-treated sow than control sows (p < 0.05). L-carnitine-treated sows had greater plasma concentrations of triglyceride and insulin-like growth factor (IGF)-1 and lesser plasma concentrations of glucose and IGF-binding protein (IGFBP-3) on day 60 of pregnancy (p < 0.05). A clearer structure of chorions, better-developed capillaries and absence of necrosis were observed in L-carnitine-treated sows compared with control sows. The protein abundance of IGF-1 and IGF-2 in placental chorions was greater in L-carnitine-treated sows compared with control sows (p < 0.05). This study suggests that sows fed an L-carnitine supplemented diet during pregnancy improved reproductive performance through enhancement of placental development and by increasing IGF concentrations in blood plasma and placental chorions.


Asunto(s)
Carnitina/metabolismo , Corion/efectos de los fármacos , Factor I del Crecimiento Similar a la Insulina/metabolismo , Leche/química , Placentación/efectos de los fármacos , Reproducción/efectos de los fármacos , Porcinos/fisiología , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales/efectos de los fármacos , Animales , Carnitina/administración & dosificación , Corion/química , Dieta/veterinaria , Suplementos Dietéticos/análisis , Femenino , Leche/efectos de los fármacos , Embarazo
10.
Mol Hum Reprod ; 23(11): 786-802, 2017 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-29040664

RESUMEN

STUDY QUESTION: Does coumestrol inhibit proliferation of human placental choriocarcinoma cells? SUMMARY ANSWER: Coumestrol promotes cell death in the choriocarcinoma cells by regulating ERK1/2 MAPK and JNK MAPK signaling pathways and through disruption of Ca2+ and ROS homeostasis. WHAT IS KNOWN ALREADY: A number of patients who suffer from choriocarcinomas fail to survive due to delayed diagnosis or a recurrent tumor and resistance to traditional chemotherapy using platinum-based agents and methotrexate. To overcome these limitations, it is important to discover novel compounds which have no adverse effects yet can inhibit the expression of a target molecule to develop, as a novel therapeutic for prevention and/or treatment of choriocarcinomas. STUDY DESIGN, SIZE, DURATION: Effects of coumestrol on human placental choriocarcinoma cell lines, JAR and JEG3, were assessed in diverse assays in a dose- and time-dependent manner. PARTICIPCANTS/MATERIALS, SETTING, METHODS: Effects of coumestrol on cell proliferation, apoptosis (annexin V expression, propidium iodide staining, TUNEL and invasion assays), mitochondria-mediated apoptosis, production of reactive oxygen species (ROS), lipid peroxidation, glutathione levels and endoplasmic reticulum (ER) stress proteins in JAR and JEG3 cells were determined. Signal transduction pathways in JAR and JEG3 cells in response to coumestrol were determined by western blot analyses. MAIN RESULTS AND THE ROLE OF CHANCE: Results of the present study indicated that coumestrol suppressed proliferation and increased apoptosis in JAR and JEG3 cells by inducing pro-apoptotic proteins, Bax and Bak. In addition, coumestrol increased ROS production, as well as lipid peroxidation and glutathione levels in JAR and JEG3 cells. Moreover, coumestrol-induced depolarization of mitochondrial membrane potential (MMP) and increased cytosolic and mitochondrial Ca2+ levels in JAR and JEG3 cells. Consistent with those results, treatment of JAR and JEG3 cells with a Ca2+ chelator and an inhibitor of IP3 receptor decreased coumestrol-induced depolarization of MMP and increased proliferation in JAR and JEG3 cells. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: A lack of in vivo animal studies is a major limitation of this research. The effectiveness of coumestrol to induce apoptosis of human placental choriocarcinoma cells requires further investigation. WIDER IMPLICATIONS OF THE FINDINGS: Our results indicate that coumestrol induces apoptotic effects on placental choriocarcinoma cells by regulating cell signaling and mitochondrial-mediated functions, with a potential to impair progression of the cancer. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (No. HI15C0810 awarded to G.S. and HI17C0929 awarded to W.L.).


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Cumestrol/farmacología , Células Epiteliales/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica , Mitocondrias/efectos de los fármacos , Fitoestrógenos/farmacología , Apoptosis/genética , Calcio/agonistas , Calcio/metabolismo , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Corion/efectos de los fármacos , Corion/metabolismo , Corion/patología , Relación Dosis-Respuesta a Droga , Estrés del Retículo Endoplásmico/efectos de los fármacos , Células Epiteliales/metabolismo , Células Epiteliales/patología , Glutatión/metabolismo , Humanos , Peroxidación de Lípido , MAP Quinasa Quinasa 4/genética , MAP Quinasa Quinasa 4/metabolismo , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Mitocondrias/metabolismo , Mitocondrias/patología , Proteína Quinasa 1 Activada por Mitógenos/genética , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/genética , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Especies Reactivas de Oxígeno/agonistas , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal , Proteína Destructora del Antagonista Homólogo bcl-2/agonistas , Proteína Destructora del Antagonista Homólogo bcl-2/genética , Proteína Destructora del Antagonista Homólogo bcl-2/metabolismo , Proteína X Asociada a bcl-2/agonistas , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
11.
Placenta ; 58: 25-32, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28962692

RESUMEN

INTRODUCTION: Nucleotide-binding oligomerization domain (NOD)-like receptors or NOD-like receptors (NLRs) have been implicated in several disease pathologies associated with inflammation. Since local and systemic inflammation is a hallmark of both term and preterm labour, a role for NLRs at the materno-fetal interface has been postulated. METHODS: Gene expression and immunolocalisation of NLR family members in human placenta, choriodecidua, and amnion were examined. Tissue explants were used to examine the response to activators of NOD1 (Tri-DAP), NOD2 (MDP) and NLRP3 (nigericin). Cell/tissue-free supernatants were examined for the production of interleukin (IL)-1ß, IL-6, IL-8 and IL-10 using specific ELISAs. RESULTS: Expression of transcripts for NOD1, NOD2, NLRP3, NLRC4, NLRX1, NLRP1 and NAIP and protein expression of NOD1, NOD2 and NLRP3 were a broad feature of all term gestation-associated tissues. Production of cytokines was increased significantly in response to all ligands in placenta and choriodecidua, except for MDP-induced IL-10. Similarly, there was a significant in the amnion except for MDP induced IL-1ß and IL-10 response to either agonist. IL-1ß production was dependent on caspase-1 regardless of agonist used or tissue examined. DISCUSSION: Term human gestation-associated tissues express functional NLRs which likely play a role in both sterile and pathogen-driven inflammatory responses at the materno-fetal interface.


Asunto(s)
Amnios/metabolismo , Corion/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Proteína Adaptadora de Señalización NOD1/metabolismo , Proteína Adaptadora de Señalización NOD2/metabolismo , Placenta/metabolismo , Amnios/efectos de los fármacos , Corion/efectos de los fármacos , Ácido Diaminopimélico/análogos & derivados , Ácido Diaminopimélico/farmacología , Femenino , Humanos , Interleucinas/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Nigericina/farmacología , Proteína Adaptadora de Señalización NOD1/genética , Proteína Adaptadora de Señalización NOD2/genética , Oligopéptidos/farmacología , Fenoles/farmacología , Placenta/efectos de los fármacos , Embarazo , Propionatos/farmacología
12.
Eur J Pharm Biopharm ; 117: 292-299, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28465240

RESUMEN

Chemical penetration enhancers (CPEs) have long been used for mass transport enhancement across membranes. Many CPEs are used in a solution or gel and could be a solvent. The use of CPEs is mainly limited due to their toxicity/irritation levels. This study presents the evaluation of encapsulated CPEs in nano-sized polymeric particles on the chorioamnion (CA) membrane mass transport. CPEs' mass encapsulated in nanoparticles was decreased by 10,000-fold. Interestingly, this approach resulted in a 6-fold increase in mass transport across the CA. This approach may also be used with other CPEs' base applications necessitating lower CPE concentration. Applying Ultrasound (US) has shown to increase the release rate of and also the mass transport across the CA membrane. It is proposed that encapsulated CPEs penetrate into the CA membrane thus prolonging their exposure, possibly extending their penetration into the CA membrane, while insonation also deepens their penetration into the CA membrane.


Asunto(s)
Amnios/metabolismo , Corion/metabolismo , Portadores de Fármacos/metabolismo , Composición de Medicamentos/métodos , Ácido Láctico/metabolismo , Nanopartículas/metabolismo , Ácido Poliglicólico/metabolismo , Amnios/efectos de los fármacos , Transporte Biológico/efectos de los fármacos , Transporte Biológico/fisiología , Corion/efectos de los fármacos , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/química , Femenino , Humanos , Ácido Láctico/administración & dosificación , Ácido Láctico/química , Nanopartículas/administración & dosificación , Nanopartículas/química , Técnicas de Cultivo de Órganos , Ácido Poliglicólico/administración & dosificación , Ácido Poliglicólico/química , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Embarazo
13.
Aquat Toxicol ; 185: 1-10, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28142078

RESUMEN

In order to identify the upper limits of the molecular size of chemicals to cross the chorion of zebrafish, Danio rerio, differently sized, non-toxic and chemically inert polyethylene glycols (PEGs; 2000-12,000Da) were applied at concentrations (9.76mM) high enough to provoke osmotic pressure. Whereas small PEGs were expected to be able to cross the chorion, restricted uptake of large PEGs was hypothesized to result in shrinkage of the chorion. Due to a slow, but gradual uptake of PEGs over time, molecular size-dependent equilibration in conjunction with a regain of the spherical chorion shape was observed. Thus, the size of molecules able to cross the chorion could be narrowed down precisely to ≤4000Da, and the time-dependency of the movement across the chorion could be described. To account for associated alterations in embryonic development, fish embryo toxicity tests (FETs) according to OECD test guideline 236 (OECD, 2013) were performed with special emphasis to changes in chorion shape. FETs revealed clear-cut size-effects: the higher the actual molecular weight (=size) of the PEG, the more effects (both acutely toxic and sublethal) were found. No effects were seen with PEGs of 2000 and 3000Da. In contrast, PEG 8000 and PEG 12,000 were found to be most toxic with LC50 values of 16.05 and 16.40g/L, respectively. Likewise, the extent of chorion shrinkage due to increased osmotic pressure strictly depended on PEG molecular weight and duration of exposure. A reflux of water and PEG molecules into the chorion and a resulting re-shaping of the chorion could only be observed for eggs exposed to PEGs ≤4000Da. Results clearly indicate a barrier function of the zebrafish chorion for molecules larger than 3000 to 4,000Da.


Asunto(s)
Corion/metabolismo , Embrión no Mamífero/metabolismo , Pruebas de Toxicidad Aguda , Contaminantes Químicos del Agua/metabolismo , Pez Cebra/embriología , Pez Cebra/metabolismo , Animales , Corion/efectos de los fármacos , Embrión no Mamífero/efectos de los fármacos , Peso Molecular , Ósmosis/efectos de los fármacos , Óvulo/efectos de los fármacos , Polietilenglicoles/toxicidad , Factores de Tiempo
14.
Reprod Sci ; 24(6): 934-953, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-27852921

RESUMEN

Inflammasomes are cytosolic signaling platforms that regulate the activation of caspase (CASP)-1, which induces the maturation of interleukin (IL)-1ß and IL-18. Herein, we determined whether the chorioamniotic membranes from women in spontaneous labor at term with acute histologic chorioamnionitis express major inflammasome components and whether these changes are associated with the activation of CASP-1 and CASP-4 and the release of mature IL-1ß and IL-18. When comparing the chorioamniotic membranes from women in spontaneous labor at term with acute histologic chorioamnionitis to those without this placental lesion, we found that (1) the messenger RNA (mRNA) abundance of NLR family pyrin domain containing 3 ( NLRP3), NLR family CARD domain containing 4 ( NLRC4), absent in melanoma 2 ( AIM2), and nucleotide binding oligomerization domain 2 ( NOD2) was higher; (2) the NLRP3 and NLRC4 protein quantities were increased; (3) the mRNA and protein expressions of CASP-1 and its active forms were greater; (4) CASP-4 was increased at the mRNA level only; (5) the mRNA and protein expressions of IL-1ß and its mature form were higher; and (6) a modest increase in the total protein concentration and abundance of the mature form of IL-18 was observed. In vitro incubation of the chorioamniotic membranes with the CASP-1 inhibitor, VX765, decreased the release of endotoxin-induced IL-1ß and IL-18 (2-fold) but not IL-6 or tumor necrosis factor α. In conclusion, spontaneous labor at term with acute histologic chorioamnionitis is characterized by an upregulation of inflammasome components which, in turn, may participate in the activation of CASP-1 and lead to the release of mature IL-1ß by the chorioamniotic membranes. These results support a role for the inflammasome in the mechanisms responsible for spontaneous labor at term with acute histologic chorioamnionitis.


Asunto(s)
Corioamnionitis/inmunología , Inflamasomas/inmunología , Trabajo de Parto/inmunología , Nacimiento a Término/inmunología , Adolescente , Adulto , Amnios/efectos de los fármacos , Amnios/inmunología , Amnios/metabolismo , Amnios/patología , Caspasa 1/metabolismo , Caspasas Iniciadoras/metabolismo , Corioamnionitis/metabolismo , Corioamnionitis/patología , Corion/efectos de los fármacos , Corion/inmunología , Corion/metabolismo , Corion/patología , Dipéptidos/farmacología , Femenino , Humanos , Inflamasomas/metabolismo , Interleucina-18/metabolismo , Interleucina-1beta/metabolismo , Trabajo de Parto/metabolismo , Embarazo , Nacimiento a Término/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Adulto Joven , para-Aminobenzoatos/farmacología
15.
Biol Reprod ; 95(6): 130, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27806943

RESUMEN

Spontaneous preterm labor occurs in two subsets of patients with sterile intra-amniotic inflammation, a process induced by alarmins such as high-mobility group box-1 (HMGB1). Inflammasomes are implicated in the process of spontaneous preterm labor. Therefore, we investigated whether HMGB1 initiates an inflammasome-associated inflammatory response in the chorioamniotic membranes. Incubation of the chorioamniotic membranes with HMGB1 1) induced the release of mature IL-1beta and IL-6; 2) upregulated the mRNA expression of the pro-inflammatory mediators NFKB1, IL6, TNF, IL1A, IFNG, and HMGB1 receptors RAGE and TLR2; 3) upregulated the mRNA expression of the inflammasome components NLRP3 and AIM2 as well as NOD proteins (NOD1 and NOD2); 4) increased the protein concentrations of NLRP3 and NOD2; 5) increased the concentration of caspase-1 and the quantity of its active form (p20); and 6) upregulated the mRNA expression and active form of MMP-9. In addition, HMGB1 concentrations in chorioamniotic membrane extracts from women who underwent spontaneous preterm labor were greater than in those from women who had undergone spontaneous labor at term. Collectively, these results show that HMGB1 can induce an inflammatory response in the chorioamniotic membranes, which is partially mediated by the inflammasome. These results provide insight into the mechanisms whereby HMGB1 induces preterm labor and birth in mice and explain why the concentration of this alarmin is increased in women who undergo spontaneous preterm labor.


Asunto(s)
Amnios/efectos de los fármacos , Corion/efectos de los fármacos , Proteína HMGB1/farmacología , Inflamasomas/metabolismo , Mediadores de Inflamación/metabolismo , Inflamación/metabolismo , Adulto , Amnios/metabolismo , Caspasa 1/metabolismo , Corion/metabolismo , Femenino , Humanos , Inflamación/inducido químicamente , Fosforilación , Nacimiento Prematuro/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Adulto Joven
16.
Methods Mol Biol ; 1473: 89-98, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27518627

RESUMEN

The field of toxicology is undergoing a vast change with high-throughput (HT) approaches that rapidly query huge swaths of chemico-structural space for bioactivity and hazard potential. Its practicality is due in large part to switching from high-cost, low-throughput mammalian models to faster and cheaper alternatives. We believe this is an improved approach because the immense breadth of the resulting data sets a foundation for predictive structure-activity-based toxicology. Moreover, rapidly uncovering structure-related bioactivity drives better decisions about where to commit resources to drill down to a mechanism, or pursue commercial leads. While hundreds of different in vitro toxicology assays can collectively serve as an alternative to mammalian animal model testing, far greater efficiency and ultimately more relevant data are obtained from the whole animal. The developmental zebrafish, with its well-documented advantages over many animal models, is now emerging as a true biosensor of chemical activity. Herein, we draw on nearly a decade of experience developing high-throughput toxicology screens in the developmental zebrafish to summarize the best practices in fulfilling the better, faster, cheaper goals. We include optimization and harmonization of dosing volume, exposure paradigms, chemical solubility, chorion status, experimental duration, endpoint definitions, and statistical analysis.


Asunto(s)
Corion/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento , Xenobióticos/farmacología , Animales , Corion/crecimiento & desarrollo , Corion/ultraestructura , Embrión no Mamífero , Pruebas de Toxicidad , Pez Cebra
17.
Fertil Steril ; 105(5): 1241-1246, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-26820772

RESUMEN

OBJECTIVE: To determine the frequency of subchorionic hematomas (SCH) in first-trimester ultrasound examinations of patients with infertility and recurrent pregnancy loss (RPL) and in patients from a general obstetric population. To determine if the method of assisted reproduction utilized or the use of anticoagulants, such as heparin and aspirin (ASA), influenced frequency of SCH. DESIGN: Prospective, cohort study. SETTING: Fertility clinic and general obstetrics clinic. PATIENT(S): Five hundred and thirty-three women who were pregnant in the first-trimester. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE(S): Frequencies of subchorionic hematomas in women based on diagnosis, use of anticoagulants, and fertility treatment. RESULT(S): SCH were identified in 129/321 (40.2%) in the study group compared to 23/212 (10.9%) in the control group. Fertility diagnosis and the use of heparin did not appear to affect the frequency of SCH in the first trimester; however, SCH occurred at an almost four-fold increase in patients taking ASA compared to those not taking ASA, regardless of fertility diagnosis or method of fertility treatment. CONCLUSION(S): The use of ASA may be associated with an increased risk of developing a SCH during the first trimester. The increased frequencies of SCH in pregnancies of patients attending a fertility clinic compared to women from a general obstetrical practice was highly correlated with the use of ASA.


Asunto(s)
Aspirina/administración & dosificación , Aspirina/efectos adversos , Corion/diagnóstico por imagen , Hematoma/diagnóstico por imagen , Complicaciones del Embarazo/diagnóstico por imagen , Adulto , Corion/efectos de los fármacos , Estudios de Cohortes , Femenino , Hematoma/inducido químicamente , Humanos , Persona de Mediana Edad , Embarazo , Complicaciones del Embarazo/inducido químicamente , Estudios Prospectivos
18.
PLoS One ; 10(8): e0134755, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26292096

RESUMEN

Morphology and physiology of fish embryos undergo dramatic changes during their development until the onset of feeding, supplied only by endogenous yolk reserves. For obtaining an insight how these restructuring processes are reflected by body mass related parameters, dry weights (dw), contents of the elements carbon and nitrogen and lipid and protein levels were quantified in different stages within the first four days of embryo development of the zebrafish (Danio rerio). The data show age dependent changes in tissue composition. Dry weights decreased significantly from 79µgdw/egg at 0hours post fertilization (hpf) to 61 µgdw/egg after 96 hpf. The amounts of total carbon fluctuated between 460 mg g-1 and 540 mg g-1 dw, nitrogen was at about 100 mg g-1 dw and total fatty acids were between 48-73 mg g-1 dw. In contrast to these parameters that remained relatively constant, the protein content, which was 240 mg g-1 at 0 hpf, showed an overall increase of about 40%. Comparisons of intact eggs and dechorionated embryos at stages prior to hatching (24, 30, 48 hpf) showed that the differences seen for dry weight and for carbon and nitrogen contents became smaller at more advanced stages, consistent with transition of material from the chorion to embryo tissue. Further, we determined the effect of 2,4-dinitrophenol at a subacutely toxic concentration (14 µM, LC10) as a model chemical challenge on the examined body mass related parameters. The compound caused significant decreases in phospholipid and glycolipid fatty acid contents along with a decrease in the phospholipid fatty acid unsaturation index. No major changes were observed for the other examined parameters. Lipidomic studies as performed here may thus be useful for determining subacute effects of lipophilic organic compounds on lipid metabolism and on cellular membranes of zebrafish embryos.


Asunto(s)
2,4-Dinitrofenol/efectos adversos , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/metabolismo , Desarrollo Embrionario/efectos de los fármacos , Lípidos/química , Proteínas/metabolismo , Pez Cebra/metabolismo , Animales , Índice de Masa Corporal , Carbono/metabolismo , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Corion/efectos de los fármacos , Corion/metabolismo , Huevos , Ácidos Grasos/metabolismo , Nitrógeno/metabolismo
19.
Environ Sci Technol ; 49(16): 10147-54, 2015 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-26171725

RESUMEN

Graphene oxide (GO) is a widely used carbonaceous nanomaterial. To date, the influence of natural organic matter (NOM) on GO toxicity in aquatic vertebrates has not been reported. During zebrafish embryogenesis, GO induced a significant hatching delay and cardiac edema. The intensive interactions of GO with the chorion induces damage to chorion protuberances, excessive generation of (•)OH, and changes in protein secondary structure. In contrast, humic acid (HA), a ubiquitous form of NOM, significantly relieved the above adverse effects. HA reduced the interactions between GO and the chorion and mitigated chorion damage by regulating the morphology, structures, and surface negative charges of GO. HA also altered the uptake and deposition of GO and decreased the aggregation of GO in embryonic yolk cells and deep layer cells. Furthermore, HA mitigated the mitochondrial damage and oxidative stress induced by GO. This work reveals a feasible antidotal mechanism for GO in the presence of NOM and avoids overestimating the risks of GO in the natural environment.


Asunto(s)
Desarrollo Embrionario/efectos de los fármacos , Grafito/toxicidad , Sustancias Húmicas/análisis , Pez Cebra/embriología , Animales , Corion/efectos de los fármacos , Corion/ultraestructura , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/metabolismo , Grafito/química , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Mitocondrias/ultraestructura , Nanoestructuras/química , Estrés Oxidativo/efectos de los fármacos
20.
Am J Obstet Gynecol ; 213(4): 520.e1-9, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26070709

RESUMEN

OBJECTIVE: Inflammation/infection and abruption are leading causes of preterm premature rupture of the membranes. Recently, we identified granulocyte-macrophage colony-stimulating factor (GM-CSF) as a critical mediator of both tumor necrosis factor-α- (TNF; modeling inflammation) and thrombin-induced (modeling abruption) weakening of the fetal membranes. We found that (1) TNF and thrombin both induced GM-CSF in the choriodecidua, (2) blockade of GM-CSF action with neutralizing antibodies inhibited both TNF- and thrombin-induced fetal membrane weakening, and (3) GM-CSF alone induced fetal membrane weakening. GM-CSF is thus part of an overlap of the inflammation and abruption-induced fetal membrane weakening pathways. The effects of progesterone analogs on the pathways by which fetal membranes are weakened have not been investigated. We examined the effects of progesterone, medroxyprogesterone acetate (MPA) and 17α-hydroxyprogesterone (HP) on TNF- and thrombin-induced fetal membrane weakening. STUDY DESIGN: Full-thickness fetal membranes from uncomplicated term repeat cesarean deliveries were mounted in Transwell inserts in Minimum Essential Medium alpha and incubated at 37°C in 5% CO2. The choriodecidua side of the fetal membrane fragments were preincubated with progesterone, MPA, HP, or vehicle for 24 hours. Fetal membranes were then exposed to TNF, thrombin, or GM-CSF on the choriodecidua side for an additional 48 hours. The fetal membrane tissues were then strength tested, and medium from the choriodecidua and amnion compartments was assayed for GM-CSF content. RESULTS: TNF and thrombin both weakened fetal membranes and elevated media GM-CSF levels on the choriodecidua side of the fetal membrane. Pretreatment with progesterone, MPA, or HP inhibited both TNF- and thrombin-induced fetal membrane weakening and also inhibited the induced increase in GM-CSF. GM-CSF decreased fetal membrane rupture strength by 68%, which was inhibited by progestogen pretreatment with a potency order: progesterone

Asunto(s)
Corion/efectos de los fármacos , Decidua/efectos de los fármacos , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Hemostáticos/farmacología , Progesterona/farmacología , Progestinas/farmacología , Trombina/farmacología , Factor de Necrosis Tumoral alfa/farmacología , 17-alfa-Hidroxiprogesterona/farmacología , Membranas Extraembrionarias/efectos de los fármacos , Femenino , Rotura Prematura de Membranas Fetales , Humanos , Técnicas In Vitro , Acetato de Medroxiprogesterona/farmacología , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...